← Leaderboards
Leo Robert Fitzpatrick
Apogee Biotechnology Corporation
$996,642
Attributed
$996,642
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $515.2K · FY2008–09$1M$750K$500K$250K$0
'08
'09
Funding mix
By agency
NIH$996,642 · 1
By mechanism
R44$996,642 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseEtiologyDesignDisease ProgressionDrug KineticsEnzymesAdjuvantArthritisDisease-Modifying Second-Line DrugsAdrenal Cortex HormonesAnimalsAdjuvant ArthritisAntiarthritic AgentCell WallClinical TreatmentClinical Trial Protocol DocumentClinical TrialsCollagenCollagen ArthritisAttenuatedCytokineDegenerative PolyarthritisDependency (Psychology)Frequencies (Time Pattern)